title: Use of cytomegalovirus antigenemia as a marker for preemptive treatment.
authors.affiliation: Renal Transplantation Unit, Puigvert Foundation, Barcelona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Guirado
authors.forename: M A
authors.initials: MA
authors.lastname: Herreros
authors.forename: J M
authors.initials: JM
authors.lastname: Muñoz
authors.forename: N
authors.initials: N
authors.lastname: Rabella
authors.forename: C
authors.initials: C
authors.lastname: Facundo
authors.forename: I
authors.initials: I
authors.lastname: Agraz
authors.forename: M
authors.initials: M
authors.lastname: Díaz
authors.forename: J M
authors.initials: JM
authors.lastname: Diaz
authors.forename: F
authors.initials: F
authors.lastname: Durán
authors.forename: R
authors.initials: R
authors.lastname: Solà
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000956:Antigens, Viral / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D010750:Phosphoproteins / Q000097:blood; D011183:Postoperative Complications / Q000821:virology*; D014763:Viral Matrix Proteins / Q000097:blood
chemical_list: D000956:Antigens, Viral; D015415:Biomarkers; D007166:Immunosuppressive Agents; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa; D015774:Ganciclovir